Drugs Pharma

Johnson & Johnson pulls out of HIV phase III trial

Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.

Read More
Medical

Hetero buys J&J’s manufacturing site in India

HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private.

Read More